This regulatory report is being submitted as part of a retrospective review and remediation per (b)(4) due to an fda audit observation.Concomitant medical products: 419688 lead implanted (b)(6) 2009 7000 lead implanted (b)(6) 2008 1788tc lead implanted (b)(6) 2008 this information was received from the hvad destination therapy post approval study.Product event summary: ventricular assist device (vad) (b)(4) was not returned for evaluation.This complaint is associated with a clinical adverse event.Information received from the site indicated that a chest x-ray that revealed that, two days post-implant, the patient had a small left pleural effusion.Based on the available information, including the occurrence of the event within two days of implant, the device may have caused or contributed to the reported event.Per the instructions for use, pleural effusion is a known potential complication associated with the implantation of a vad.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulant and antiplatelet medications and the patient's complex post-operative course.There is possible patient, pharmacological and procedural factors that may have contributed to this event.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.If information is provided in the future, a supplemental report will be issued.
|